Dasatinib tablets 20mg “BMSH” by Bristol-Myers Squibb Sales contains Dasatinib hydrate, a tyrosine kinase inhibitor for treating Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL). It is supplied as 20mg 1 tablet with YJ code 4291020F1078.
Dasatinib tablets 20mg “BMSH”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
